EGFR and lung cancer: This study aims to develop and validate an 18F-FDG PET/CT radiogenomic model on the basis of 18F-FDG PET/CT radiomics and clinical-parameter EGFR to predict the PFS stratification of SBRT in lung-cancer patients.